KCNH1 and breast carcinoma: Furthermore, drug induced blockade of Kv10.1 expression, with the tricyclic antidepressant (TA) imipramine [22] and with astemizole in breast cancer cells [23], in both cases with IC50 in the low micromolar range, resulted in anti-tumorigenic effects.